Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-12 Purchase | 2024-02-14 7:04 pm | Kyverna Therapeutics Inc. | KYTX | Vida Ventures LLC Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner | 253,136 | $22 | $5,568,992 | 583 (Indirect) | View |
| 2024-02-12 Purchase | 2024-02-14 5:26 pm | Kyverna Therapeutics Inc. | KYTX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences III General Partner LLC Bain Capital Life Sciences Fund III L.P. Bain Capital Life Sciences Opportunities III GP LLC Bain Capital Life Sciences Opportunities III LP 10% Owner | 450,000 | $22 | $9,900,000 | 3,163,868 (Indirect) | View |
| 2024-02-12 Purchase | 2024-02-13 5:48 pm | Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner | 910,000 | $22 | $20,020,000 | 4,126,119 (Direct) | View |
| 2024-02-12 Purchase | 2024-02-12 5:51 pm | Kyverna Therapeutics Inc. | KYTX | Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. Former 10% Owner | 450,000 | $22 | $9,900,000 | 450,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-12 Conversion | 2024-02-14 7:04 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Vida Ventures LLC Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner | 25,112,758 | $0 | 583 (Indirect) | View |
| 2024-02-12 Conversion | 2024-02-14 7:03 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Cohen Fred E Director 10% Owner | 25,112,758 | $0 | 4,523,924 (Indirect) | View |
| 2024-02-12 Conversion | 2024-02-14 6:56 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director 10% Owner | 25,112,758 | $0 | 735,984 (Indirect) | View |
| 2024-02-12 Conversion | 2024-02-14 5:35 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC Harper Sean E 10% Owner | 25,112,758 | $0 | 735,984 (Indirect) | View |
| 2024-02-12 Conversion | 2024-02-14 5:26 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences III General Partner LLC Bain Capital Life Sciences Fund III L.P. Bain Capital Life Sciences Opportunities III GP LLC Bain Capital Life Sciences Opportunities III LP 10% Owner | 15,064,955 | $0 | 3,163,868 (Indirect) | View |
| 2024-02-12 Conversion | 2024-02-13 5:48 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner | 17,853,002 | $0 | 4,126,119 (Direct) | View |
| 2024-02-12 Conversion | 2024-02-12 5:51 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. Former 10% Owner | 15,573,202 | $0 | 450,000 (Indirect) | View |
Ownership | 2024-02-07 9:58 pm | N/A 2031-04-26 | Kyverna Therapeutics Inc. | KYTX | SPIEGELMAN DANIEL K Director | 0 | $0 | 50,537 (Direct) | View |
Ownership | 2024-02-07 9:58 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Borie Dominique Christian See Remarks | 0 | $0 | 562,630 (Indirect) | View |
Ownership | 2024-02-07 9:58 pm | N/A 2031-11-17 | Kyverna Therapeutics Inc. | KYTX | CLARK IAN T Director | 0 | $0 | 364,398 (Direct) | View |
Ownership | 2024-02-07 9:58 pm | N/A 2033-11-05 | Kyverna Therapeutics Inc. | KYTX | Cohen Fred E Director 10% Owner | 0 | $0 | 4,556,883 (Direct) | View |
Ownership | 2024-02-07 9:57 pm | N/A 2031-11-17 | Kyverna Therapeutics Inc. | KYTX | Walker Karen Marie Chief Technology Officer | 0 | $0 | 203,246 (Direct) | View |
Ownership | 2024-02-07 9:57 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Chung James Bum Chief Medical Officer | 0 | $0 | 209,838 (Direct) | View |
Ownership | 2024-02-07 9:57 pm | 2022-08-28 2029-08-27 | Kyverna Therapeutics Inc. | KYTX | Kotzin Brian L. Director | 0 | $0 | 76,265 (Direct) | View |
Ownership | 2024-02-07 9:56 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Vida Ventures LLC 10% Owner | 0 | $0 | 4,523,924 (Direct) | View |
Ownership | 2024-02-07 9:56 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Jones Ryan Alexander Chief Financial Officer | 0 | $0 | 179,074 (Direct) | View |
Ownership | 2024-02-07 9:55 pm | N/A 2033-11-05 | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director 10% Owner | 0 | $0 | 4,556,883 (Direct) | View |
Ownership | 2024-02-07 9:55 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Maag Peter Chief Executive Officer | 0 | $0 | 1,727,972 (Direct) | View |
Ownership | 2024-02-07 9:51 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC Harper Sean E 10% Owner | 0 | $0 | 4,523,924 (Indirect) | View |
Ownership | 2024-02-07 9:23 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences III General Partner LLC Bain Capital Life Sciences Fund III L.P. Bain Capital Life Sciences Opportunities III GP LLC Bain Capital Life Sciences Opportunities III LP 10% Owner | 0 | $0 | 2,713,868 (Indirect) | View |
Ownership | 2024-02-07 8:30 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. 10% Owner | 0 | $0 | 2,805,426 (Indirect) | View |
Ownership | 2024-02-07 5:35 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 3,216,119 (Direct) | View |